Acadesine increases blood flow in the collateralized heart during exercise

Journal of Cardiovascular Pharmacology

Volumn 32, Issue 4, 1998, Pages 552-561

  Ishibashi, Yutaka ^a,b   Quebbeman, Brian B ^a   Duncker, Dirk J ^a,c   Klassen, Christopher ^a   Bache, Robert J ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b SHIMANE UNIVERSITY   (Japan)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Adenosine; Collateral vessel; Coronary occlusion; Myocardial ischemia

Indexed keywords

5 AMINO 4 IMIDAZOLECARBOXAMIDE RIBOSIDE; ADENOSINE; ADENOSINE TRIPHOSPHATASE; ATRIAL NATRIURETIC FACTOR; CALCITONIN GENE RELATED PEPTIDE; GLYCERYL TRINITRATE; URIC ACID;

ANGIOGENESIS; ANIMAL EXPERIMENT; ARTICLE; BLOOD FLOW VELOCITY; COLLATERAL CIRCULATION; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY COLLATERAL CIRCULATION; CORONARY VASCULAR RESISTANCE; DOG; DRUG DISTRIBUTION; DRUG HALF LIFE; DRUG MECHANISM; EXERCISE; HEART INFARCTION; HEART MUSCLE OXYGEN CONSUMPTION; HEART PROTECTION; HEMODYNAMIC PARAMETERS; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; TREADMILL EXERCISE;

ADENOSINE; AMINOIMIDAZOLE CARBOXAMIDE; ANIMALS; COLLATERAL CIRCULATION; CORONARY CIRCULATION; DOGS; FEMALE; HEART; HEMODYNAMIC PROCESSES; INFUSIONS, INTRAVENOUS; MALE; MYOCARDIAL ISCHEMIA; PHYSICAL CONDITIONING, ANIMAL; RIBONUCLEOSIDES;

EID: 0031710590     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199810000-00007     Document Type: Article

References (35)

1. Schaper W. The collateral circulation of the heart. Amsterdam: Nonh Holland Publishing, 1971:5-65.
2. Hautamaa PV, Dai X, Homans DC, Bache RJ. Vasomotor activity of moderately well-developed canine coronary collateral circulation. Am J Physiol 1989;256:H890-7.
3. Foreman B, Dai XZ, Homans DC, Laxson DD, Bache RJ. Effects of atrial natriuretic peptide on coronary collateral blood flow. Circ Res 1989;65:1671-8.
4. Quebbeman BB, Dulas D, Altman J, Homans DC, Bache RJ. Effect of calcitonin gene-related peptide on well-developed canine coronary collateral vasculature. J Cardiovasc Pharmacol 1992;21: 774-80.
5. Belardinelli L, Linden J, Berne RM. The cardiac effects of adenosine. Prog Cardiovasc Dis 1989;32:73-97.
6. Ely SW, Berne RM. Protective effects of adenosine in myocardial ischemia. Circulation 1992;85:893-904.
7. Hori M, Tamai J, Kitakaze K, et al. Adenosine-induced hyperemia attenuates myocardial ischemia in coronary microembolization in dogs. Am J Physiol 1989;257:H244-51.
8. Schaper W, Lewi P, Flameng W, Gijpen L. Myocardial steal produced by coronary vasodilation in chronic coronary occlusion Basic Res Cardiol 1973;68:3-20.
9. Verani MS, Mahmarian JJ, Hixson JB, Boyce TM, Staudacher RA. Diagnosis of coronary artery disease by controlled coronary vasodilation with adenosine and thallium-201 scintigraphy in patients unable to exercise. Circulation 1990;82:80-7.
10. Mitsos SE, Jolly SR, Lucchesi BR. Protective effects of AICA riboside in the globally ischemic isolated cat heart. Pharmacology 1985;31:121-31.
11. Galinanes M, Bullough D, Mullane KM, Hearse DJ. Sustained protection by acadesine against ischemia - and reperfusion-induced injury: studies in the transplanted rat heart. Circulation 1992;86: 589-97.
12. Young MA, Mullane KM. Progressive cardiac dysfunction with repeated pacing-induced ischemia: protection by AICA-riboside. Am J Physiol 1991;261:H1570-7.
13. Hori M, Kitakaze M, Takashima S, et al. AICA riboside improves myocardial ischemia in coronary microembolization in dogs. Am J Physiol 1994;267:H1483-95.
14. Gruber HE, Hoffer ME, McAllister DR, et al. Increased adenosine concentration in blood from ischemic myocardium by AICA riboside: effects on flow, granulocytes, and injury. Circulation 1989; 80:1400-11.
15. Gwirtz P. Construction and evaluation of a coronary catheter for chronic implantation in dogs. J Appl Physiol 1986;60:720-6.
16. Franklin D, McKown D, Hastley J, Caldwell M. Development and regression of coronary collaterals induced by repeated, reversible ischemia in dogs [Abstract]. Fed Proc 1981;40:339.
17. Patterson RE, Kirk ES. Apparent improvement in canine collateral myocardial blood flow during vasodilation depends on criteria used to identify ischemic myocardium. Circ Res 1980;47:108-16.
18. Foreman BW, Dai XZ, Bache RJ. Vasoconstriction of canine coronary collateral vessels with vasopressin limits blood flow to collateral-dependent myocardium during exercise. Circ Res 1991;69:657-64.
19. Canty JM, Klocke FL. Myocardial perfusion and metabolism: reductions in regional myocardial function at rest in conscious dogs with chronically reduced regional coronary artery pressure. Circ Res 1987;61(suppl II):II-107-16.
20. Ball RM, Bache RJ. Distribution of myocardial blood flow in the exercising dog with restricted coronary artery inflow. Circ Res 1976;38:60-6.
21. Sun KT, Czernin J, Krivokapich J, et al. Effects of dobutamine stimulation on myocardial blood flow, glucose metabolism, and wall motion in normal and dysfunctional myocardium. Circulation 1996;94:3146-54.
22. Lambert PR, Hess DS, Bache RJ. Effect of exercise on perfusion of collateral-dependent myocardium in dog with chronic coronary artery occlusion. J Clin Invest 1977;59:1-7.
23. Longhurst JC, Motohara S, Atkins JM, Ordway GA. Function of mature coronary collateral vessels and cardiac performance in the exercising dog. J Appl Physiol 1985;59:392-400.
24. Bache RJ, Schwanz JS. Myocardial blood flow during exercise after gradual coronary occlusion in the dog. Am J Physiol 1983;245-H131-8.
25. Schwartz JS, Baran KW, Bache RJ. Effect of stenosis on exercise-induced dilation of large coronary arteries. Am Heart J 1990;119: 520.
26. Selke FW, Quillen JE, Brooks LA, Harrison DG. Endothelial modulation of the coronary vasculature in vessels perfused via mature collaterals. Circulation 1990;81:1938-47.
27. Harrison DG, Chilian WC, Marcus ML. Absence of functioning alpha-adrenergic receptors in mature canine coronary collaterals. Circ Res 1986;59:133-12.
28. Schaper W, Flameng W, Winkler B, et al. Quantification of collateral resistance in acute and chronic experimental coronary occlusion in the dog. Circ Res 1976;39:371-7.
29. Granato JE, Watson DD, Belardinelli L, Cannon JM, Beller GA. Effects of dipyridamole and aminophylline on hemodynamics, regional myocardial blood flow and thallium-201 washout in the setting of a critical coronary stenosis. J Am Coll Cardiol 1990;16: 1760-70.
30. Przyklenk K, Bauer B, Ovize M, Kloner RA, Whittaker P. Regional ischemic "preconditioning" protects remote virgin myocardium from subsequent sustained coronary occlusion. Circulation 1993; 87: 893-9.
31. Kitakaze M, Hori M, Morioka T, et al. Infarct size-limiting effect of ischemic preconditioning is blunted by inhibition of 5′-nucleotidase activity and attenuation of adenosine release. Circulation 1994;89:1237-16.
32. Kitakaze M, Komamura K, Tamai N. Evidence for induction of myocardial ectosolic 5′-nucleotidase in acute myocardial infarction [Abstract]. Circulation 1994;90:2287.
33. Dixon R, Gourziz J, McDermott D, Fujitaki J, Dewland P, Gruber H. AICA riboside:safety, tolerance and pharmacokinetics of a novel adenosine-regulating agent. J Clin Pharmacol 1991;31:342-7.
34. Leung JM, Stanley T, Mathew J, et al. An initial multicenter, randomized controlled trial on the safety and efficiency of acadesine in patients undergoing coronary artery bypass graft surgery: SPI research group. Anesth Analg 1994;78:420-34.
35. Holdright DR, Sparrow JL, Wright CL, Steiner J, Fox KM. Effect of acadesine, a new metabolic agent, on exercise-induced myocardial ischemia in chronic stable angina. Cardiovasc Drugs Ther 1994;8:193-7.